Alopecia/Vitiligo Clinical Trial

Alopecia Areata (AA) is a condition that causes hair loss when the immune system attacks hair follicles. It is estimated to affect 2% of the population worldwide. Many patients with AA have chronic relapses, and some can have complete hair loss.

Vitiligo is a condition that causes loss of skin colour in patches due to the immune system attacking skin cells that produce melanin. It affects between 0.5% and 2% of the population and may be linked to other autoimmune diseases.

Who can take part?

You may be eligible if you are:

* Over 18 years old

* Have been diagnosed with alopecia with over 20% scalp hair loss for at least 6 months

OR

* Have been diagnosed with vitiligo with some face involvement and have at least one active lesion

This study will be commencing soon at CGM Research. Contact us if you would like more information about possible participation.

h.

Register your Interest

Sponsors + Partners

Clinical Trial Companies NZ

+64 3 365 6777
enquiries@cgm.org.nz
Level 3, 800 Colombo Street
Christchurch Central City
Christchurch, 8013

©2024 CGM Research Trust Ltd.  |   Website Developed by Happy Monday Ltd